暗記メーカー

暗記メーカー

​
ログイン

CELLULAR ABERRATION

CELLULAR ABERRATION
63問 • 2年前
  • Kharylle Salvador
    • 通報

    問題一覧

  • 1

    Neoplasm that originates the lymphoids

    Lymphomas

  • 2

    Period of time during which an anti neoplastic medication has its most profound effects on the blood components

    Nadir

  • 3

    Neoplasm that originates from the muscles, bone, fat, lymph system or connective tissue

    Sarcomas

  • 4

    new growth which may be benign or malignant

    Neoplasm

  • 5

    Spread of cancer to nearby tissue

    Invasion

  • 6

    Spread of cancer to other organs or other parts of the body

    Metastasis

  • 7

    no specific function

    Undifferentiation

  • 8

    Program and controlled cell destruction which eliminates damaged, improperly produce and worn out cells without harming the other areas

    Apoptosis

  • 9

    Neoplasm that originates from blood forming organs

    Leukemia or myelomas

  • 10

    Normal gene that can become oncogene

    Protooncogenes

  • 11

    Specific body substance that indicate tumor progression or regression

    Tumor Markers

  • 12

    Cells that have lost capacity or specialized functions

    Undifferentiated cells

  • 13

    rapid cell division

    Proliferation

  • 14

    disease process that occurs due to transformation of mutated DNA genes

    Cancer

  • 15

    new growth which may be benign or malignant

    Neoplasm

  • 16

    A process which normal body cells have individual characteristics allowing them to perform different body functions

    Differentiation

  • 17

    A physical, chemical, or biological stressor that cause neoplastic changes in abnormal cells

    Carcinogen

  • 18

    New growth or malignant tumor that originates from epithelial cells, skin, GIT, lungs, uterus, breast and other organs

    Carcinoma

  • 19

    Term for growth that mestasize and grow and are cancerous lesions that are disordered, uncontrolled, and chaotic proliferation of cells

    Malignant

  • 20

    dominant genes, only one allele needs to be stated to cause cancer

    Proto-oncogene Mutation

  • 21

    Cancer cells avoid apoptosis

    Tumor Suppressor Gene Mutation

  • 22

    PMAT

    ...

  • 23

    DNA REPLICATION

    s phase

  • 24

    Resting/ dominant phase

    G0

  • 25

    Time after the formation of cell, rna, protein synthesis

    G1

  • 26

    Continues Rna

    G2

  • 27

    cells not yet destined to replicate

    Go

  • 28

    Chromosomes uncoiled and become chromatin

    Telophase

  • 29

    Chromosomes allign midway

    Metaphase

  • 30

    Centrioles moves to opposite sides

    Prophase

  • 31

    Potentially malignant

    Dysplasia

  • 32

    Conversion of one type of cell in a tissue to another type not normal for that tissue

    Metaplasia

  • 33

    Uncontrolled growth of cells that remain in same location remove asap

    carcinoma in situ

  • 34

    Excessive rate of cell division

    Hyperplasia l

  • 35

    uncontrolled cell growth

    Neoplasia

  • 36

    originates from blood cell from forming tissue

    Hematological cancer

  • 37

    Associated with the organs from which they develop

    Solid tumor

  • 38

    Carcinogen change the DNA of the cell causing cell formation

    Initiation

  • 39

    the ability to invade and mestasize

    Progression

  • 40

    repeated exposure to carcinogen

    Promotion

  • 41

    Stable not life threatening

    Benign

  • 42

    Cancerous, invasive

    Malignant

  • 43

    Tumor marker for testicular, liver cancer

    AFP ALPHA FETOPROTEIN

  • 44

    Tumor marker for breast cancer

    CA 15-3

  • 45

    Tumor marker for colorectal, breast, lung cancer

    CEA Carcinoembryonic Antigen

  • 46

    Tumor marker for ovarian cancer

    CA 125

  • 47

    Tumor marker for prostate marker

    PSA Prostate specific antigen

  • 48

    Bone metastasis tumor marker

    Alkaline phosphatase

  • 49

    Gestational trophoblastic disease

    HCG

  • 50

    Recurrence of bladder cancer

    Nuclear matrix protein 22

  • 51

    Primary tumor cannot be assessed

    Tx

  • 52

    Increasing size and /or local extent of primary tumor

    T1-T4

  • 53

    No evidence pf primary tumor

    To

  • 54

    Distance mastasis cannot be assessed

    Mx

  • 55

    Distant mestasis

    M1

  • 56

    No distant mestasis

    Mo

  • 57

    No regional lymph node metastasis

    No

  • 58

    Increasing involvement of regional lymph nodes

    N1-N3

  • 59

    Metastasis stage

    4

  • 60

    Carcinoma in situ

    1

  • 61

    Limited local spread. Ti nearby area but stillin primary site

    3

  • 62

    Extensive Local and regional spread

    3

  • 63

    Tumor limited to the tissue of origin

    1

    • Raynaud's Phenomenon

    Raynaud's Phenomenon

    Kharylle Salvador · 8問 · 2年前

    Raynaud's Phenomenon

    Raynaud's Phenomenon

    8問 • 2年前
    Kharylle Salvador

    Varicose Veins

    Varicose Veins

    Kharylle Salvador · 5問 · 2年前

    Varicose Veins

    Varicose Veins

    5問 • 2年前
    Kharylle Salvador

    ETHICO-LEGAL

    ETHICO-LEGAL

    Kharylle Salvador · 54問 · 2年前

    ETHICO-LEGAL

    ETHICO-LEGAL

    54問 • 2年前
    Kharylle Salvador

    RLE

    RLE

    Kharylle Salvador · 52問 · 2年前

    RLE

    RLE

    52問 • 2年前
    Kharylle Salvador

    COPAR RLE

    COPAR RLE

    Kharylle Salvador · 25問 · 2年前

    COPAR RLE

    COPAR RLE

    25問 • 2年前
    Kharylle Salvador

    Chemotherapy

    Chemotherapy

    Kharylle Salvador · 8問 · 2年前

    Chemotherapy

    Chemotherapy

    8問 • 2年前
    Kharylle Salvador

    Blood Disorders (ANEMIA)

    Blood Disorders (ANEMIA)

    Kharylle Salvador · 11問 · 2年前

    Blood Disorders (ANEMIA)

    Blood Disorders (ANEMIA)

    11問 • 2年前
    Kharylle Salvador

    Research

    Research

    Kharylle Salvador · 20問 · 2年前

    Research

    Research

    20問 • 2年前
    Kharylle Salvador

    Immune System

    Immune System

    Kharylle Salvador · 19問 · 2年前

    Immune System

    Immune System

    19問 • 2年前
    Kharylle Salvador

    FLUIDS AND ELECTROLYTES

    FLUIDS AND ELECTROLYTES

    Kharylle Salvador · 32問 · 2年前

    FLUIDS AND ELECTROLYTES

    FLUIDS AND ELECTROLYTES

    32問 • 2年前
    Kharylle Salvador

    Therapeutic Communication

    Therapeutic Communication

    Kharylle Salvador · 16問 · 2年前

    Therapeutic Communication

    Therapeutic Communication

    16問 • 2年前
    Kharylle Salvador

    PSYCH

    PSYCH

    Kharylle Salvador · 12問 · 2年前

    PSYCH

    PSYCH

    12問 • 2年前
    Kharylle Salvador

    MS RLE

    MS RLE

    Kharylle Salvador · 46問 · 1年前

    MS RLE

    MS RLE

    46問 • 1年前
    Kharylle Salvador

    問題一覧

  • 1

    Neoplasm that originates the lymphoids

    Lymphomas

  • 2

    Period of time during which an anti neoplastic medication has its most profound effects on the blood components

    Nadir

  • 3

    Neoplasm that originates from the muscles, bone, fat, lymph system or connective tissue

    Sarcomas

  • 4

    new growth which may be benign or malignant

    Neoplasm

  • 5

    Spread of cancer to nearby tissue

    Invasion

  • 6

    Spread of cancer to other organs or other parts of the body

    Metastasis

  • 7

    no specific function

    Undifferentiation

  • 8

    Program and controlled cell destruction which eliminates damaged, improperly produce and worn out cells without harming the other areas

    Apoptosis

  • 9

    Neoplasm that originates from blood forming organs

    Leukemia or myelomas

  • 10

    Normal gene that can become oncogene

    Protooncogenes

  • 11

    Specific body substance that indicate tumor progression or regression

    Tumor Markers

  • 12

    Cells that have lost capacity or specialized functions

    Undifferentiated cells

  • 13

    rapid cell division

    Proliferation

  • 14

    disease process that occurs due to transformation of mutated DNA genes

    Cancer

  • 15

    new growth which may be benign or malignant

    Neoplasm

  • 16

    A process which normal body cells have individual characteristics allowing them to perform different body functions

    Differentiation

  • 17

    A physical, chemical, or biological stressor that cause neoplastic changes in abnormal cells

    Carcinogen

  • 18

    New growth or malignant tumor that originates from epithelial cells, skin, GIT, lungs, uterus, breast and other organs

    Carcinoma

  • 19

    Term for growth that mestasize and grow and are cancerous lesions that are disordered, uncontrolled, and chaotic proliferation of cells

    Malignant

  • 20

    dominant genes, only one allele needs to be stated to cause cancer

    Proto-oncogene Mutation

  • 21

    Cancer cells avoid apoptosis

    Tumor Suppressor Gene Mutation

  • 22

    PMAT

    ...

  • 23

    DNA REPLICATION

    s phase

  • 24

    Resting/ dominant phase

    G0

  • 25

    Time after the formation of cell, rna, protein synthesis

    G1

  • 26

    Continues Rna

    G2

  • 27

    cells not yet destined to replicate

    Go

  • 28

    Chromosomes uncoiled and become chromatin

    Telophase

  • 29

    Chromosomes allign midway

    Metaphase

  • 30

    Centrioles moves to opposite sides

    Prophase

  • 31

    Potentially malignant

    Dysplasia

  • 32

    Conversion of one type of cell in a tissue to another type not normal for that tissue

    Metaplasia

  • 33

    Uncontrolled growth of cells that remain in same location remove asap

    carcinoma in situ

  • 34

    Excessive rate of cell division

    Hyperplasia l

  • 35

    uncontrolled cell growth

    Neoplasia

  • 36

    originates from blood cell from forming tissue

    Hematological cancer

  • 37

    Associated with the organs from which they develop

    Solid tumor

  • 38

    Carcinogen change the DNA of the cell causing cell formation

    Initiation

  • 39

    the ability to invade and mestasize

    Progression

  • 40

    repeated exposure to carcinogen

    Promotion

  • 41

    Stable not life threatening

    Benign

  • 42

    Cancerous, invasive

    Malignant

  • 43

    Tumor marker for testicular, liver cancer

    AFP ALPHA FETOPROTEIN

  • 44

    Tumor marker for breast cancer

    CA 15-3

  • 45

    Tumor marker for colorectal, breast, lung cancer

    CEA Carcinoembryonic Antigen

  • 46

    Tumor marker for ovarian cancer

    CA 125

  • 47

    Tumor marker for prostate marker

    PSA Prostate specific antigen

  • 48

    Bone metastasis tumor marker

    Alkaline phosphatase

  • 49

    Gestational trophoblastic disease

    HCG

  • 50

    Recurrence of bladder cancer

    Nuclear matrix protein 22

  • 51

    Primary tumor cannot be assessed

    Tx

  • 52

    Increasing size and /or local extent of primary tumor

    T1-T4

  • 53

    No evidence pf primary tumor

    To

  • 54

    Distance mastasis cannot be assessed

    Mx

  • 55

    Distant mestasis

    M1

  • 56

    No distant mestasis

    Mo

  • 57

    No regional lymph node metastasis

    No

  • 58

    Increasing involvement of regional lymph nodes

    N1-N3

  • 59

    Metastasis stage

    4

  • 60

    Carcinoma in situ

    1

  • 61

    Limited local spread. Ti nearby area but stillin primary site

    3

  • 62

    Extensive Local and regional spread

    3

  • 63

    Tumor limited to the tissue of origin

    1